Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,536,596
-$83,030 QoQ
Shares Held
7,920
-0.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GABELLI FUNDS LLC holds $96,689,277 across 29 Biotechnology names. VRTX ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
195,900 | $22,493,238 | |
| 2 | TERN |
Terns Pharmaceuticals, Inc.
|
271,857 | $14,332,301 | |
| 3 | FOLD |
AMICUS THERAPEUTICS, INC.
|
942,650 | $13,630,719 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
321,200 | $12,921,876 | |
| 5 | DAWN |
Day One Biopharmaceuticals, Inc.
|
464,097 | $9,950,239 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
65,300 | $4,849,178 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
7,920 | $3,536,596 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
46,200 | $2,985,906 |
All Filings in VRTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,536,596 | 7,920 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,619,626 | 7,984 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,875,383 | 15,002 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,269,670 | 16,329 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,926,807 | 16,350 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,117,319 | 17,674 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,091,926 | 17,399 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,354,962 | 22,092 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,325,385 | 22,309 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,272,616 | 22,789 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,888,134 | 22,684 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,146,364 | 23,149 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $7,763,639 | 24,641 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,689,299 | 23,164 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,371,617 | 22,006 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,355,000 | 26,101 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,906,943 | 37,962 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $6,872,601 | 31,296 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,588,441 | 25,296 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,991,096 | 9,875 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||